Seeing Is Believing

Currently out of the existing stock ratings of James Lee, 403 are a BUY (72.09%), 14 are a SELL (2.5%), 142 are a HOLD (25.4%).
Analyst James Lee, carries an average stock price target met ratio of 61.02% that have a potential upside of 40.25% achieved within 165 days. Previously, James Lee worked at MIZUHO.
James Lee’s has documented 1,106 price targets and ratings displayed on 51 stocks. The coverage was on Communication Services, Consumer Cyclical, Healthcare, Technology sectors.
Most recent stock forecast was given on BABA, Alibaba Group Holding Ltd at 16-May-2025.
Analyst best performing recommendations are on CORT (CORCEPT THERAPEUTICS).
The best stock recommendation documented was for CORT (CORCEPT THERAPEUTICS) at 8/2/2023. The price target of $29 was fulfilled within 1 day with a profit of $3.99 (15.95%) receiving and performance score of 159.54.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$145
$17.01 (13.29%)
$148
7 days ago
(23-Oct-2025)
16/19 (84.21%)
$17.01 (13.29%)
139
Hold
$160
8 days ago
(22-Oct-2025)
8/10 (80%)
$32.27 (25.26%)
165
Hold
24 days ago
(06-Oct-2025)
2/2 (100%)
$16.99 (9.82%)
49
Buy
$151
$23.01 (17.98%)
$160
1 months 1 days ago
(29-Sep-2025)
14/16 (87.5%)
$29.58 (24.36%)
57
Sell
$104
$-23.99 (-18.74%)
$106
1 months 28 days ago
(02-Sep-2025)
4/6 (66.67%)
$-20.9 (-16.73%)
29
Which stock is James Lee is most bullish on?
Which stock is James Lee is most reserved on?
What Year was the first public recommendation made by James Lee?